Virtual Reality for Patient Informed Consent in Neurosurgery
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Oct 2, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of virtual reality (VR) to help patients better understand the informed consent process for neurosurgery. Informed consent is an important step where patients learn about their surgery, including the risks and benefits, so they can make informed decisions. By using VR, researchers hope to see if this technology can improve how well patients understand these details, strengthen the relationship between patients and doctors, and reduce any anxiety patients might feel about their surgery.
To participate in this trial, patients need to be between 18 and 75 years old and scheduled for specific types of neurosurgery, such as surgery for brain aneurysms or tumors. However, those with certain visual or hearing issues, past experience with VR for informed consent, or certain mental health conditions may not be eligible. If you join the study, you will experience the VR technology designed to help you learn about your surgery in a new and engaging way. This innovative approach aims to create a more supportive and informative environment for patients facing neurosurgical procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients between the age of 18 and 75
- • Surgical clipping for intracranial aneurysm, resection of vascular malformations
- • Craniotomy and Resection of intracranial tumors that can be segmented for VR
- Exclusion Criteria:
- • Visual or auditory impairment with no sufficient aid
- • Patient that had VR informed consent for surgery before
- • Psychiatric illness, cognitive impairment
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Emilia Westarp, Dr.
Principal Investigator
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported